Bicycle Therapeutics Ltd (BCYC)vsRevolution Medicines Inc (RVMD)
BCYC
Bicycle Therapeutics Ltd
$3.82
-1.55%
HEALTHCARE · Cap: $247.43M
RVMD
Revolution Medicines Inc
$190.27
+0.82%
HEALTHCARE · Cap: $40.45B
Smart Verdict
WallStSmart Research — data-driven comparison
Bicycle Therapeutics Ltd generates 8149% more annual revenue ($61.20M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. BCYC earns a higher WallStSmart Score of 31/100 (F).
BCYC
Avoid31
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Distress zone — elevated risk
Smaller company, higher risk/reward
0.0% margin — thin
Trading at 15.6x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : BCYC
The strongest argument for BCYC centers on Price/Book, Debt/Equity.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : BCYC
The primary concerns for BCYC are EPS Growth, Altman Z-Score, Market Cap.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
BCYC carries more volatility with a beta of 1.68 — expect wider price swings.
BCYC is growing revenue faster at -78.5% — sustainability is the question.
BCYC generates stronger free cash flow (-50M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BCYC scores higher overall (31/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Bicycle Therapeutics Ltd
HEALTHCARE · BIOTECHNOLOGY · USA
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments. The company is headquartered in Cambridge, the United Kingdom.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?